Drug Manufacturers
Page 1 of 33
- GlaxoSmithKline Makes Generics Deal to Penetrate Emerging Markets
- ARIUS Research: Stock Up on Roche Takeover Bid
- The Long Case for Abbott Laboratories
- Earnings Preview: Bristol Myers Squibb
- Earnings Preview: Becton, Dickinson and Co.
- Earnings Preview: Eli Lilly & Co.
- Roche Is on a Spending Spree
- Pfizer Beats: Recommended at or Below $18
- Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone
- Just What the Doctor Ordered: Comparing the Pharma ETFs
- Biotech Buying Binge About to Begin?
- Did Merck's Sex and the City Strategy Work?
- Eisai Victorious Over Teva and Dr. Reddy’s in Aciphex Compound Patent Case
- Merck/Schering-Plough's Heart Drug Couldn't Have Done Worse
- Clarifying the Vytorin Situation: Three Key Questions
- Earnings Preview: Wyeth
- Earnings Preview: Pfizer
- Roche's Genentech Offer Sends Ripples Through Biotech
- Earnings Preview: Biogen Idec
- HPC Vaccine Inspires Yellow Health Journalism
- Earnings Preview: Forest Laboratories
- Is Pfizer the Cure for a Weak Market?
- Abbott: Too Overvalued to Make a Good Dividend Investment?
- Roche Offers to Buy 45% Stake in Genentech
- Expecting Strong Upside from Biogen on Merrill Call
- Pfizer Stock: Value Trap?
- ETF Update: Focus on Health
- PTC and Genzyme in $437M Gene Therapy Deal
- Teva Buys Barr Pharmaceuticals
- Gilead Sciences: Industry Landscape, Strong Growth Make It a Buy
- Earnings Preview: Schering-Plough Corp.
- Earnings Preview: Merck & Co.
- Why I Bought Illumina
- Merck Victorious over Apotex in Fosamax Counterclaims Case
- Is Teva Looking to Buy Barr Pharmaceuticals?
- Will Lilly's Survey Have the Desired Effect on Cialis?
- Abbott Proves Successful in a Very Tough Market
- Big Biotech Booms But IBB Falls Flat
- Earnings Preview: Baxter International
- Cardiome Pharma: More Encouraging Trial Results
- Johnson & Johnson's Future Looks Bright
- A Fat Yield at Pfizer
- Allos Therapeutics Looks Promising Ahead of Crucial 6 Months
- Eli Lilly: Good Dividend but Is the Stock Worth the Risk?
- Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal
July 24, 2008
| Last Updated
08:32
ET
Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- Avistar Communications Corporation Q2 2008 Earnings Call Transcript
- Chipotle Mexican Grill, Inc. Q2 2008 Earnings Call Transcript
- Baidu Q2 2008 Earnings Call Transcript
- Sybase, Inc. Q2 2008 Earnings Call Transcript
- F5 Networks, Inc. F3Q08 (Qtr End 06/30/08) Earnings Call Transcript
- Raymond James Financial, Inc. F3Q08 (Qtr. End 06/30/08) Earnings Call Transcript
- Conceptus, Inc. Q2 2008 Earnings Call Transcript
- S&T Bancorp, Inc. Q2 2008 Earnings Call Transcript
- Varian, Inc. F3Q08 (Qtr. End 06/30/08) Earnings Call Transcript
- MEMC Electronic Materials, Inc. Q2 2008 Earnings Call Transcript
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
-
Editor's Picks
-
Most Popular
- A Fed Rate Hike Won't Solve the Current Crisis
- Understanding Metastorm's IPO as an Investment Opportunity
- Mr. Cuomo, ARS Investors Don't Need a Spitzeresque Settlement
- A Long Housing Boom Won't Yield to a Brief Recovery
- Why Congress Blames Index Speculators
- What Are the Prospects for Stagflation?
- Full list of Editor's Picks »
- Three Stocks To Be Held To Infinity and Beyond »
- As WaMu, Wachovia Ready Earnings, Comparisons to Wells, USB Are Telling »
- Wall Street Breakfast: Must-Know News »
- Steve Jobs' Health: A Red Herring »
- Financials: How - And When - We Reached the Bottom »
- Four Long-Term Winners Selling at Deep Discounts »
- Apple F3Q08 (Qtr End 6/28/08) Earnings Call Transcript »
- Earnings Preview: Washington Mutual »
- Crazy Dividends »
- The Agriculture Boom Goes Bust »
- Apple's a Buy Under $150 »